Tim Watts, CFO at Shield Therapeutics #STX presenting at our Life Sciences Investor Briefing Watch Now

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,671.60
Bid: 1,659.20
Ask: 1,660.20
Change: 13.80 (0.83%)
Spread: 1.00 (0.06%)
Open: 1,649.20
High: 1,678.20
Low: 1,646.40
Yest. Close: 1,657.80
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

GSK Finds Anaemia Treatment Option, ViiV Presents 3-Year Research Data

LONDON (Alliance News) - GlaxoSmithKline PLC on Monday said the results from a phase 3 study of daprodustat in Japanese patients with anaemia showed positive results.The pharmaceutical said

29 Oct 18 10:39

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 25 October Lloyds Banking GroupQ3 ResultsRELXQ3 ResultsAir 26

24 Oct 18 16:09

TOP NEWS: GSK Reports Encouraging Results From Arthritis Drug Trial

LONDON (Alliance News) - GlaxoSmithKline PLC on Sunday said a phase two study of its rheumatoid arthritis drug showed promising results.The drug, GSK3196165, is also known as GSK165 and was

22 Oct 18 07:26

GlaxoSmithKline's ViiV Healthcare Submits New HIV Drug Application

LONDON (Alliance News) - GlaxoSmithKline PLC on Thursday said ViiV Healthcare has submitted a new drug application to the US Food & Drug Administration.The submission covers a two-drug

18 Oct 18 16:47

Monday broker round-up

(Sharecast News) - Mediclinic International: Investec upgrades to buy with a target price of 448p.

8 Oct 18 13:07

GSK Vaccine Significantly Reduces Tuberculosis In Infected Patients

LONDON (Alliance News) - GlaxoSmithKline PLC on Tuesday said it candidate vaccine, M72/AS01E, was shown to significantly reduce pulmonary tuberculosis in adults with latent tuberculosis results of

25 Sep 18 18:42

LONDON MARKET CLOSE: Pound Falls On Brexit Impasse, Stocks End Higher

LONDON (Alliance News) - Stocks ended the week on a high as UK Prime Minster Theresa May's speech on Brexit caused the pound to tumble Friday afternoon, in turn, driving the FTSE 100 are in as

21 Sep 18 17:21

Glaxo Gets Positive EMA Opinion For Label Expansion Of Trelegy Ellipta

LONDON (Alliance News) - GlaxoSmithKline PLC on Friday said it has received a positive opinion on broadening the use of its Trelegy Ellipta inhaler in patients with chronic obstructive pulmonary a

21 Sep 18 13:06

Savills Appoints Two New Independent Non-Executive Directors

LONDON (Alliance News) - Savills PLC said Wednesday it appointed Stacey Cartwright and Florence Tondu-Melique as independent non-executive directors with effect from October.The real estate

19 Sep 18 13:27

PRESS: GlaxoSmithKline To Shortlist Bidders For Horlicks Unit - FT

LONDON (Alliance News) - Competition is rising to secure GlaxoSmithKline PLC's Horlicks malted milk hot beverage brand, with offers in the range of USD2.5 billion to USD3 billion, the Times no

19 Sep 18 07:15

Meggit Hires Former Victrex Finance Director As New CFO

LONDON (Alliance News) - Aerospace company Meggitt PLC said Tuesday that Chief Financial Officer Doug Webb will retire from the company at the end of December.The FTSE 250-listed company as

18 Sep 18 08:51

GSK's ViiV seeks approval for new one-tablet HIV-1 treatment

(Sharecast News) - ViiV Healthcare - the HIV specialist majority-owned by GlaxoSmithKline, alongside minority shareholders Pfizer and Shionogi - announced the submission of a marketing authorisation application to the European Medicines Agency on Friday, for a single-tablet, two-drug regimen of dolutegravir and lamivudine for the treatment of the HIV-1 infection.

14 Sep 18 09:20

GlaxoSmithKline pleased with recent Nucala results

(Sharecast News) - GlaxoSmithKline announced results on Monday from an indirect treatment comparison of the licensed doses of Nucala (mepolizumab), compared to benralizumab and reslizumab, in patients with severe eosinophilic asthma.

10 Sep 18 08:39

More work needed for mepolizumab application, says GlaxoSmithKline

(Sharecast News) - GlaxoSmithKline has received a 'complete response letter' from the United States Food and Drug Administration regarding its application for mepolizumab, it announced on Monday.

10 Sep 18 07:22

BROKER RATINGS SUMMARY: Goldman Cuts Burberry; Redburn Cuts HSBC

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:----------FTSE 100----------GOLDMAN CUTS GROUP TO BUY -

7 Sep 18 09:33

Login to your account

Don't have an account? Click here to register.